Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of ...
New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...
Why Is Silexion Therapeutics Stock Soaring Over 100% On Tuesday?
Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data for SIL-204, its next-generation siRNA therapeutic ...
Silexion Therapeutics reports preclinical data for SIL-204
Silexion Therapeutics (SLXN) announced new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. The findings ...